glucagon has been researched along with td-5108 in 2 studies
| Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (td-5108) | Trials (td-5108) | Recent Studies (post-2010) (td-5108) |
|---|---|---|---|---|---|
| 26,039 | 1,498 | 3,054 | 340 | 52 | 216 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, K; Kamiyama, H; Masuda, K; Terauchi, Y; Togashi, Y | 1 |
| Chen, JD; Han, HS; Kim, HW; Song, G; Xu, X; Yin, J | 1 |
1 trial(s) available for glucagon and td-5108
| Article | Year |
|---|---|
Mosapride citrate, a 5-HTâ‚„ receptor agonist, increased the plasma active and total glucagon-like peptide-1 levels in non-diabetic men.
Topics: Adult; Benzamides; Blood Glucose; Gastric Inhibitory Polypeptide; Gastrointestinal Agents; Gastrointestinal Tract; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Insulin; Male; Morpholines; Postprandial Period; Serotonin 5-HT4 Receptor Agonists; Up-Regulation | 2013 |
1 other study(ies) available for glucagon and td-5108
| Article | Year |
|---|---|
Prokinetic effects of a new 5-HT
Topics: Administration, Oral; Animals; Benzamides; Carbamates; Dogs; Dose-Response Relationship, Drug; Gastric Emptying; Gastrointestinal Motility; Gastroparesis; Glucagon; Pyloric Antrum; Serotonin 5-HT4 Receptor Agonists | 2017 |